Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.65) per share. This is a 71.05 percent decrease over losses of $(0.38) per share from the same period last year.
Raymond James Maintains Outperform on Regions Financial, Raises Price Target to $24
Raymond James analyst Michael Rose maintains Regions Financial (NYSE:RF) with a Outperform and raises the price target from $23 to $24.